Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

dynaCERT: Growth Rocket 2025 – Why It’s in the Spotlight

As 2024 draws to a close, it is worth considering new investments for the future. A successful investment in the technology sector requires a sound strategy, thorough research, and an understanding of the ins and outs of the industry. We have summarized key points for in...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

GameSquare's power moves: Strategic growth, and what's ahead

The following is a transcription of the above video, and The Market Online has edited it for clarity . GameSquare Holdings (NDAQ:GAME) is an international digital media, entertainment and technology company that enables global brands to connect with gaming and yout...

DynaCERT: Is this the hour of hydrogen?

Daimler Truck must reduce forecasts It is a challenging time for transportation companies. By 2030, fleet operators in the EU will have to meet specific requirements to reduce CO2 emissions. The EU has introduced stricter CO2 standards for heavy-duty vehicles, requi...

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...

Drilling company poised to capitalize on market conditions

The following is a transcription of the above video, and The Market Online has edited it for clarity . AKITA Drilling (TSX:AKT.A) is a leading intermediate North American land drilling contractor that is valued far below its assets with a fleet of 36 high-spec rigs...

Buzz on the Bullboards: Major developments amidst market dynamics

This week, the North American stock markets managed to showcase some contrasted performances. While the NASDAQ and S&P 500 reached record highs, driven by optimism around potential Federal Reserve rate cuts, the Dow Jones also enjoyed a solid rally. Meanwhile, the TS...

Nvidia! Turnaround for Nel, Saturn Oil & Gas, Lufthansa, TUI?

It looks like a peak is forming in artificial intelligence. The most prominent share here is Nvidia (NDAQ:NVDA) . With a spectacular rally, the value has surged by more than 100 per cent in just six months. However, the share price is now stuttering, and there have been ...

BASF and Cardiol Therapeutics recommended buys; TUI rides momentum

BASF (OTCQX:BASFY) shares have gained over 30% within six months. But is the rally in BASF shares slowly running out of steam? The fact that the stock did not rise sharply yesterday despite a significant price target increase suggests this is the case. Many experts see ...

Buzz on the Bullboards: Highlights from Bay Street to Wall Street

As investors reflect on the past week’s market movements, it’s clear that some notable shifts have taken place in the Canadian and U.S. stock markets. On Bay Street, the Toronto Stock Exchange witnessed intriguing developments, while Wall S...
1 2 3 4 5 6 7 8 9 10 ...